Evidence map›Paper›PMID 28195856›Full record

ArticlePain2017

Pharmacoepidemiologic analyses of opioid use among OEF/OIF/OND veterans.

Teresa J Hudson, Jacob T Painter, Bradley C Martin, Mark A Austen, James S Williams, John C Fortney, Mark D Sullivan, Mark J Edlund

Open access · hybridAbstract read
In one paragraph

Article in Pain, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 1 pooled it
7.2field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 1 synthesis or guideline pooled it, 59 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Scoping Review of Opioid Use After Traumatic Brain Injury.The Journal of head trauma rehabilitation
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 1 country.

Teresa J HudsonaDepartment of Psychiatry, University of Arkansas for Medical Sciences, Little Rock, AR, USA bCenter for Mental Healthcare and Outcomes Research, Central Arkansas Veterans Healthcare System, Little Rock, AR, USA cDivision of Pharmaceutical Evaluation and Policy, Department of Pharmacy Practice, University of Arkansas for Medical Sciences, Little Rock, AR, USA dDepartment of Psychiatry, School of Medicine, University of Washington, Seattle, WA, USA eHSR&D, Center of Innovation for Veteran-Centered and Value-Driven Care, VA Puget Sound Health Care System, Seattle, WA, USA fBehavioral Health Epidemiology Program, RTI International, Research Triangle Park, NC, USA gBehavioral Health Services, St. Luke's Health System, Twin Falls, ID, USA.
Jacob T Painter
Bradley C Martin
Mark A Austen
James S Williams
John C Fortney
Mark D Sullivan
Mark J Edlund
Central Arkansas Veterans Healthcare System · USBehavioral Health Services · USUniversity of Arkansas for Medical Sciences · USUniversity of Washington · USVA Puget Sound Health Care System · US

Funding

Use and Abuse of Prescription Opioids Among OEF/OIF VeteransR01DA030300 · NIDA · UNIV OF ARKANSAS FOR MED SCIS · PI EDLUND, MARK J., HUDSON, TERESA JO · 2010 to 2013
$1.2M
NIDA NIH HHS R01 DA030300
6 · The paper itself

Abstract

There is a great deal of concern about opioid use in veterans, particularly those who served in Afghanistan (OEF) and Iraq (OIF and OND). The current study provides a detailed pharmacoepidemiologic analysis of opioid use among OEF/OIF/OND veterans from FY09 to FY12. Data from 3 data repositories from the Veterans Health Administration (VHA) were used to describe demographic, clinical, and medication characteristics associated with opioid use among OEF/OIF/OND veterans and among those with TBI. Logistic regression models were used to identify risks associated with chronic opioid use in FY12. Approximately 23% of all OEF/OIF/OND veterans and 35% of those with TBI received any opioid medications. Most received moderate doses ranging from 26 to 30 mg morphine equivalent dose daily. Median days of opioid use for all OEF/OIF/OND veterans were 30 to 40 days. Factors associated with chronic use in both groups included young age, male sex, white race, being married, and living in rural areas. A diagnosis of PTSD (odds ratio [OR] = 1.22, P < 0.0001), major depressive disorder (OR = 1.14, P < 0.0001), and tobacco use disorder (OR = 1.18, P < 0.0001) were strongly associated with chronic opioid use. Back pain was also strongly associated with chronic use (OR = 2.50, P < 0.0001). As pain severity increased the odds of chronic opioid use also increased: mild pain (OR = 3.76, P < 0.0001), moderate pain (OR = 6.80, P < 0.0001), and severe pain (OR = 8.49, P < 0.0001). Opioid use among OEF/OIF/OND veterans is characterized by moderate doses that are used over relatively long periods of time by a minority of veterans.

Indexed as

Afghan Campaign 2001-Iraq War, 2003-2011AdultAnalgesics, OpioidChronic PainComorbidityDrug UtilizationFemaleHumansMajor Depressive DisorderMalePain MeasurementPharmacoepidemiologyPrevalenceRisk FactorsStress Disorders, Post-TraumaticAnalgesics, Opioid

Identifiers

PMID28195856
PMCPMC5427984
OpenAlexW2588521848

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.